Ischemic Stroke: Clinical Trials

62 trials for Ischemic Stroke, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

62 completed. 62 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 462Completed 62

Follow Ischemic Stroke: new trials by email Literature Review of Ischemic Stroke trials Research Report on Ischemic Stroke

Trials (filtered) newest first · largest first

All 62 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion
Tirofiban, Acetylsalicylic acid - Acute Ischemic Stroke
Phase 4CompletedFundación Pública Andaluza para la gestión de la Investigación en Sevilla2402026-03-202026-04-03
Early Administration of PCSK9 Inhibitors After Thrombectomy for Atherosclerotic Acute Ischemic Stroke: A Randomized Controlled Trial
Evolocumab(420 mg injections) - Acute Stroke
Phase 4CompletedThe Affiliated Hospital of Xuzhou Medical University602025-12-202026-07-13
Nicardipine vs. Labetalol
nicardipine intravenous, labetalol intravenous - Acute Ischemic Stroke, Hypertensive Crisis
Phase 4CompletedHaseki Training and Research Hospital342025-02-012025-12-11
Oral DLBS1033 as Adjunctive Therapy in Acute Ischemic Stroke: Impact on Inflammatory Biomarkers and Outcomes
Oral lumbrokinase DLBS1033, Placebo - Ischemic Stroke, Acute
Phase 4CompletedUniversitas Sebelas Maret522024-07-062026-10-14
Comparison of Perioperative Conscious Sedation During Endovascular Thrombectomy in Acute Ischemic Stroke
Dexmedetomidine, Midazolam - Acute Ischemic Stroke
Phase 4CompletedJinling Hospital, China8102023-11-212026-09-24
Intravenous Thrombolysis With rhTNK-tPA for Acute Non-large Vessel Occlusion in Extended Time Window
rhTNK-tPA, Antiplatelet Agents - Acute Ischemic Stroke
Phase 4CompletedXuanwu Hospital, Beijing5702023-06-022025-12-02
MEXIDOL® in the Rehabilitation Treatment of Patients With Acute Cerebral Failure
Mexidol - Ischemic Stroke, Acute
Phase 4CompletedPharmasoft602023-04-172025-04-27
Precise Antiplatelet THerapy Guided by Platelet Aggregation Function in Ischemic STROKE(PATH-STROKE)
Precision Antiplatelet Therapy Trial Group, Traditional Antiplatelet Therapy Control Group - Ischemic Stroke, Antiplatelet Drug
Phase 4CompletedSichuan Provincial People's Hospital12242023-01-012026-06-15
A Study to Evaluate the Efficacy and Safety of Renexin CR in Patients With Acute Non-cardioembolic Ischemic Stroke
Renexin CR 200/160mg, Plavix 75mg - Ischemic Stroke
Phase 4CompletedSK Chemicals Co., Ltd.4832022-12-162025-11-21
Effects of Minocycline on Patients With Ischemic Stroke Undergoing Intravenous Thrombectomy
Minocycline - Ischemic Stroke, Acute
Phase 4CompletedXijing Hospital1892022-11-012026-07-29
Early Antiplatelet for Minor Stroke Following Thrombolysis (EAST)
Aspirin 100mg; Clopidogrel 300mg - Ischemic Stroke
Phase 4CompletedGeneral Hospital of Shenyang Military Region10222022-07-082024-10-31
Predictors of AIS Unfavorable Outcomes
Alteplase - Ischemic Stroke, Alteplase Adverse Reaction
Phase 4CompletedKafrelsheikh University5922022-01-032023-10-10
An Exploratory Study of Ganglioside GM1 in Acute Ischemic Stroke
Monosialoganglioside GM1 - Stroke, Ischemic
Phase 4CompletedGeneral Hospital of Shenyang Military Region3002021-07-282022-09-23
Predictors of Post-alteplase Hemorrhagic Transformation of Brain Infarction
Alteplase - Ischemic Stroke, Alteplase Adverse Reaction
Phase 4CompletedKafrelsheikh University6002021-06-012025-09-05
Clinical Study on Huatuo Zaizao Pills for Post-stroke Treatment
Huatuo Zaizao Pills, Basic treatment - Ischemic Stroke
Phase 4CompletedXiyuan Hospital of China Academy of Chinese Medical Sciences802021-05-312024-11-29
Outcome in Patients Treated with Intraarterial Thrombectomy - OptiMAL Blood Pressure Control (OPTIMAL-BP)
conventional blood pressure control (labetalol, nicardipine), intensive blood pressure control (labetalol, nicardipine) - Ischemic Stroke
Phase 4CompletedYonsei University3062020-06-182025-03-19
Study on Rosuvastatin+Ezetimibe and Rosuvastatin for LDL-C Goal in Patients With Recent Ischemic Stroke
Experimental: Rosuvastatin/Ezetimibe 10, Active Comparator: Rosuvastatin 20mg - Stroke, Ischemic
Phase 4CompletedKeun-Sik Hong5842019-09-092024-10-03
An Investigation Into The Impact Of Enteric Coated Of Aspirin In Patients With Newly Diagnosed Ischemic Stroke.
Enteric Coated Aspirin Tablet, Plain Aspirin - Stroke, Ischemic
Phase 4CompletedHamad Medical Corporation422019-08-262020-04-02
Cilostazol and Aspirin in Stroke and TIA
Cilostazol, Clopidogrel - Ischemic Stroke, TIA
Phase 4CompletedIncheon St.Mary's Hospital3782019-07-182024-08-06
Direct Mechanical Thrombectomy Versus Bridging Therapy
Trevo and or Merci devices for stent retreival, Penumbra system for stent aspiration, recombinant tissue plasminogen activator - Thrombectomy, Ischemic Stroke
Phase 4CompletedAlexandria University512019-07-012022-01-03

Showing 20 of 62. Sign in to see all of them.

Narrower conditions

Stroke (13)  ·  Aortic Valve Disease (3)  ·  Myocardial Infarction (3)  ·  Thrombosis (3)  ·  Atrial Fibrillation (2)  ·  Embolic Stroke (2)  ·  Embolism (2)  ·  Hemorrhage (2)  ·  Aortic Valve Stenosis (1)  ·  Atherosclerosis (1)  ·  Brain Injuries, Traumatic (1)  ·  Brain Ischemia (1)  ·  Cardiovascular Diseases (1)  ·  Cerebral Hemorrhage (1)

Broader conditions

Brain Diseases (62)  ·  Central Nervous System Diseases (62)  ·  Nervous System Diseases (62)  ·  Cardiovascular Diseases (61)  ·  Cerebrovascular Disorders (61)  ·  Vascular Diseases (61)  ·  Stroke (49)  ·  Pathologic Processes (8)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Heart Diseases (5)  ·  Infarction (4)  ·  Ischemia (4)  ·  Necrosis (4)  ·  Heart Valve Diseases (3)  ·  Arrhythmias, Cardiac (2)

Interventions

Aspirin (12)  ·  Clopidogrel (12)  ·  Tissue Plasminogen Activator (5)  ·  Cilostazol (4)  ·  Atorvastatin (3)  ·  Saline Solution (2)  ·  danhong (2)  ·  naoxintong (2)  ·  3-n-butylphthalide (1)  ·  Allopurinol (1)  ·  Amlodipine (1)  ·  Antihypertensive Agents (1)  ·  Dexmedetomidine (1)  ·  Edaravone (1)  ·  Fluoxetine (1)

Sponsors

China Academy of Chinese Medical Sciences (3)  ·  General Hospital of Shenyang Military Region (3)  ·  Xuanwu Hospital, Beijing (3)  ·  Ain Shams University (2)  ·  Beijing Tiantan Hospital (2)  ·  Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec (2)  ·  Jiangsu Kanion Pharmaceutical Co., Ltd (2)  ·  Jinling Hospital, China (2)  ·  Kafrelsheikh University (2)  ·  University of Alberta (2)  ·  Ajou University School of Medicine (1)  ·  Alexandria University (1)  ·  China Medical University Hospital (1)  ·  Columbia University (1)  ·  Combination Therapy for Acute Ischemic Stroke Study Group (1)

Countries

China (24)  ·  South Korea (7)  ·  Canada (6)  ·  United States (5)  ·  Austria (4)  ·  Egypt (4)  ·  Spain (4)  ·  Italy (3)  ·  Japan (3)  ·  Belgium (2)  ·  Czechia (2)  ·  Denmark (2)  ·  France (2)  ·  Germany (2)  ·  Greece (2)

Top investigators

Adem Az, Assoc. Prof. (1)  ·  Brian Buck, MD (1)  ·  Carlos Morillo, MD (1)  ·  Charlotte Rath, MD (1)  ·  Chen Huisheng, Doctor (1)  ·  Chung Y. Hsu, MD. Ph.D. (1)  ·  David M Grosvenor, MPH (1)  ·  Elena Zapata-Arrizada, PhD (1)  ·  Finlay A McAlister, MD, MSc (1)  ·  Firstiafina Tiffany, MD (1)  ·  Gao Ying, Doctor (1)  ·  Hans Christoph Diener, MD (1)  ·  J Mocco, MD, MS (1)  ·  Jesse Dawson (1)

Results publications

PMID 12221155, PMID 16731270, PMID 28527771, PMID 34515113, PMID 36446950, PMID 11786451, PMID 12045168, PMID 13678932, PMID 15232117, PMID 16176495, PMID 17437989, PMID 17448820, PMID 17515473, PMID 17698822, PMID 18757238, PMID 19336502, PMID 19380621, PMID 19696423, PMID 19762550, PMID 20075341, PMID 20096533, PMID 20334810, PMID 20437555, PMID 20566953, PMID 20837828, PMID 20837893, PMID 20961243, PMID 21030700, PMID 21098354, PMID 21125042, PMID 21216739, PMID 21502757, PMID 22282884, PMID 22633681, PMID 23055089, PMID 24135533, PMID 24206541, PMID 24733770, PMID 24876082, PMID 24963567, PMID 25394855, PMID 25401325, PMID 25458657, PMID 26182860, PMID 26374482, PMID 26654631, PMID 26763225, PMID 26920599, PMID 27043681, PMID 28596447

NIH funding

2015 (1), R01NS032525 (1)